Kelly Financial Services LLC Dexcom Inc Transaction History

Kelly Financial Services LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 12, 2024	SELL	$110.31 - $140.45 $12,795 - $16,292	-116 Reduced 62.37%	70 $7,000
Q1 2024 Jul 17, 2024	BUY	$114.22 - $140.1 $20,102 - $24,657	176 Added 1760.0%	186 $25,000
Q4 2023 Jul 17, 2024	SELL	$75.49 - $124.16 $75 - $124	-1 Reduced 9.09%	10 $1.24 Million
Q3 2023 Jul 17, 2024	BUY	$86.06 - $137.93 $946 - $1,517	11 New	11 $1.03 Million

1,014

351M

5.51M

5.6M

Ticker DXCM
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 386,257,984
Market Cap $30.9B
Description
DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM ...

Get notified when there are updates to the investment portfolio of Kelly Financial Services LLC, based on Form 13F filings with the SEC.

Stay updated on Kelly Financial Services LLC with notifications on news.